Boehringer Ingelheim expands access to Humira biosimilarBoehringer Ingelheim will manufacture adalimumab-adbm for Quallent Pharmaceuticals. Lupin appoints 2 new independent directorsJeffrey Kindler and Alfonso Zulueta are joining Lupin’s board as independent directors. Zydus obtains FDA OK for 2 generics Dexamethasone is used to treat various conditions—such as arthritis and immune system disorders—and Dapsone Gel is used to treat acne. The future of AI in pharmacy What can we learn from Kerrville Drug Co., who is using AI technology to drive more profitability in their cash business? FDA approves Strides Pharma's generic Renvela Sevelamer Carbonate is a phosphate binder that helps prevent hypocalcemia (low levels of calcium in the body). DrFirst acquires Myndshft Technologies The acquisition aims to expedite access to specialty medications. Video: 4 minutes with Vivo Health Pharmacy’s Onisis Stefas A regional player in New York state, the pharmacy will soon expand its reach. Hikma launches midazolam injection in prefilled syringe form Midazolam injection, 2mg/2ml and 10mg/2ml, had a market value of approximately $20 million for the 12 months ending February 2024, per IQVIA. Tennessee expands access to OTC cold, allergy medications containing PSE New legislation in Tennessee raises the monthly purchase limit for common OTC cold and allergy medications containing pseudoephedrine from 5.76 grams per month to 7.2 grams. FDA approves Akebia Therapeutics’ Vafseo Vafseo is used for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients. First Previous 32 33 34 35 36 Next Last
